Immediate Impact
2 by Nobel laureates 38 standout
Citing Papers
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Peter Tan being referenced
Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML).
2019
Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Tan | 123 | 28 | 79 | 108 | 18 | 243 | |
| Lorenz Bastian | 71 | 28 | 74 | 81 | 20 | 196 | |
| Shayu Deshpande | 113 | 20 | 47 | 107 | 16 | 204 | |
| Christos Demosthenous | 74 | 63 | 45 | 71 | 18 | 196 | |
| Daniel Egan | 119 | 30 | 47 | 73 | 21 | 198 | |
| Jean‐Valère Malfuson | 138 | 39 | 31 | 136 | 15 | 240 | |
| Juan Carlos Balandrán | 85 | 25 | 86 | 109 | 19 | 263 | |
| F. G. C. Jones | 119 | 82 | 49 | 124 | 18 | 281 | |
| Raphael Teipel | 131 | 38 | 28 | 55 | 21 | 185 | |
| Caroline Alvares | 113 | 23 | 30 | 127 | 20 | 234 | |
| Michela Carlet | 70 | 15 | 46 | 134 | 14 | 213 |
All Works
Loading papers...